Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
CASE REPORTS
Effectiveness of High-dose Spironolactone Therapy in a Patient with Recurrent Protein-losing Enteropathy after the Fontan Procedure
Satomi OkanoMasaya SugimotoMasashi TakaseKenichi IsekiAya KajihamaHiroshi Azuma
Author information
JOURNALS OPEN ACCESS

2016 Volume 55 Issue 12 Pages 1611-1614

Details
Abstract

Protein-losing enteropathy (PLE) is a rare and life-threatening complication that occurs after the Fontan procedure. We herein report the case of an 11-year-old Japanese boy who developed PLE six times after undergoing the Fontan procedure. High-dose spironolactone therapy has been effective for 2 years. His high level of serum aldosterone decreased to a nearly normal range and spironolactone may have a diuretic and anti-inflammatory potential.

Information related to the author
© 2016 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top